The technology to extract C-60 from natural fullerene deposits is ground-breaking and a first in this industry, said the company...
Voyageur secures exclusive rights to rare pharmaceutical mineral
Recent Posts
See AllRakovina highlighted the development of its kt-3000 drug candidates as a potential treatment of Ewing sarcoma and other soft tissue tutors..
This is the largest and highest-resolution magnetic survey completed in the history of the area.
FDA has granted the request for a meeting to review the clinical trial protocol for its Phase 3 study in high-risk COVID-19 outpatients.